Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2026 Filed Aug 10, 2026 20:08 UTC |
Butler John P.Director · CEO and President
|
Exercise / conversionStock Option (Right to buy) · Derivative | 350,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001591467-26-000004 · primarydocument.xml · derivative · entry 3 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,000 Underlying: Common Stock · 350,000 shares Expires 2033-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options were granted by the Issuer on January 31, 2023 and vest over four years: 25% of the options vested on January 31, 2024 with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| August 06, 2026 Filed Aug 10, 2026 20:08 UTC |
Butler John P.Director · CEO and President
|
Exercise / conversionCommon Stock | 350,000 | $0.63 | $220,500.00 |
DisclosureSEC source: 0001591467-26-000004 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,718,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2026 under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 20:34 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
SaleCommon Stock | 56,019 | $1.11 | $62,181.09 |
DisclosureSEC source: 0001762507-26-000004 · primarydocument.xml · nonDerivative · entry 1 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 616,616 F1 · shares: This sale represents an automatic "sell to cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units granted on June 28, 2024. The sale was effected pursuant to durable automatic sell-to-cover instructions adopted by the reporting person on September 8, 2025. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:24 UTC |
Wolf MylesDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001808317-26-000001 · primarydocument.xml · derivative · entry 2 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2036-06-17 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:24 UTC |
Wolf MylesDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001808317-26-000001 · primarydocument.xml · nonDerivative · entry 1 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,081 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:22 UTC |
ROGERS MICHAEL WDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001244159-26-000001 · primarydocument.xml · derivative · entry 2 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2036-06-17 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:22 UTC |
ROGERS MICHAEL WDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001244159-26-000001 · primarydocument.xml · nonDerivative · entry 1 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,429 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:09 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001248144-26-000001 · primarydocument.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2036-06-17 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:09 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001248144-26-000001 · primarydocument.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,200 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:10 UTC |
ZUMWALT LEANNE MDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001204946-26-000001 · primarydocument.xml · derivative · entry 2 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2036-06-17 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:10 UTC |
ZUMWALT LEANNE MDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001204946-26-000001 · primarydocument.xml · nonDerivative · entry 1 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,100 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:20 UTC |
FRIESON RONDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001890219-26-000001 · primarydocument.xml · derivative · entry 2 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2036-06-17 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:20 UTC |
FRIESON RONDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001890219-26-000001 · primarydocument.xml · nonDerivative · entry 1 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,200 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:23 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001609480-26-000003 · primarydocument.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2036-06-17 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:23 UTC |
Smith CynthiaDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001609480-26-000003 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,633 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:06 UTC |
Vickers Philip J.Director
|
GrantStock Option (Right to buy) · Derivative | 214,400 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001635046-26-000005 · primarydocument.xml · derivative · entry 1 Vickers Philip J. · CIK 0001635046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,400 Underlying: Common Stock · 214,400 shares Expires 2036-04-01 F1 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Fifth Amended and Restated Non-Employee Director Compensation Program. The Stock Option will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 23:55 UTC |
Butler John P.Director · CEO and President
|
PurchaseCommon Stock | 69,270 | $1.25 | $86,587.50 |
DisclosureSEC source: 0001591467-26-000003 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,367,064 F1 · shares: The reporting person's purchase of Akebia Therapeutics, Inc. ("Akebia") common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 69,270 shares, with the reporting person's sale of 341,305 shares of Akebia common stock at a price of $1.39 per share on February 2, 2026 pursuant to an automatic sell-to-cover instruction solely to cover applicable withholding taxes in connection with the vesting of the reporting person's RSUs granted on January 31, 2023, 2024 and 2025. The reporting person has paid Akebia, upon settlement of the sale, $9,664.60 representing the full amount of the profit realized in connection with the short-swing transaction. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:15 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
SaleCommon Stock | 13,382 | $1.39 | $18,600.98 |
DisclosureSEC source: 0002007730-26-000002 · primarydocument.xml · nonDerivative · entry 2 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 299,390 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:15 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
SaleCommon Stock | 36,142 | $1.39 | $50,237.38 |
DisclosureSEC source: 0002007730-26-000002 · primarydocument.xml · nonDerivative · entry 1 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,772 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:13 UTC |
Grund NicholasChief Commercial Officer
|
SaleCommon Stock | 31,244 | $1.39 | $43,429.16 |
DisclosureSEC source: 0001661887-26-000002 · primarydocument.xml · nonDerivative · entry 2 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 561,750 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2025. F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:13 UTC |
Grund NicholasChief Commercial Officer
|
SaleCommon Stock | 53,585 | $1.39 | $74,483.15 |
DisclosureSEC source: 0001661887-26-000002 · primarydocument.xml · nonDerivative · entry 1 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 592,994 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2025. F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:13 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 20,701 | $1.39 | $28,774.39 |
DisclosureSEC source: 0001619834-26-000002 · primarydocument.xml · nonDerivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 948,432 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:13 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 25,375 | $1.39 | $35,271.25 |
DisclosureSEC source: 0001619834-26-000002 · primarydocument.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 969,133 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:13 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 21,582 | $1.39 | $29,998.98 |
DisclosureSEC source: 0001619834-26-000002 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 994,508 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC |
Rucci Carolyn M.SVP, Chief Legal Officer
|
SaleCommon Stock | 27,544 | $1.39 | $38,286.16 |
DisclosureSEC source: 0002107264-26-000006 · primarydocument.xml · nonDerivative · entry 3 Rucci Carolyn M. · CIK 0002107264 · SVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 588,378 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC |
Rucci Carolyn M.SVP, Chief Legal Officer
|
SaleCommon Stock | 25,382 | $1.39 | $35,280.98 |
DisclosureSEC source: 0002107264-26-000006 · primarydocument.xml · nonDerivative · entry 2 Rucci Carolyn M. · CIK 0002107264 · SVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 615,922 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC |
Rucci Carolyn M.SVP, Chief Legal Officer
|
SaleCommon Stock | 16,846 | $1.39 | $23,415.94 |
DisclosureSEC source: 0002107264-26-000006 · primarydocument.xml · nonDerivative · entry 1 Rucci Carolyn M. · CIK 0002107264 · SVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 641,304 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:10 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 83,689 | $1.39 | $116,327.71 |
DisclosureSEC source: 0001591467-26-000002 · primarydocument.xml · nonDerivative · entry 5 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,297,794 F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F6 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's performance stock units granted on January 31, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:10 UTC |
Butler John P.Director · CEO and President
|
GrantCommon Stock | 175,250 | $1.41 | $247,102.50 |
DisclosureSEC source: 0001591467-26-000002 · primarydocument.xml · nonDerivative · entry 4 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,381,483 F5 · shares: As reported in February 2025, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2023 Stock Incentive Plan, as amended. Each PSU right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs vests on the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period (the "Stock Price Hurdle 1 Performance Condition"), subject to the reporting persons continuous employment through the applicable vesting date. In July2025, the Compensation Committee certified that the Stock Price Hurdle 1 Performance Condition was met during the performance period and therefore one-half of the PSUs vested on January 31, 2026. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:10 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 114,891 | $1.39 | $159,698.49 |
DisclosureSEC source: 0001591467-26-000002 · primarydocument.xml · nonDerivative · entry 3 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,206,233 F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:10 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 96,065 | $1.39 | $133,530.35 |
DisclosureSEC source: 0001591467-26-000002 · primarydocument.xml · nonDerivative · entry 2 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,321,124 F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:10 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 46,660 | $1.39 | $64,857.40 |
DisclosureSEC source: 0001591467-26-000002 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,417,189 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:11 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
SaleCommon Stock | 34,951 | $1.39 | $48,581.89 |
DisclosureSEC source: 0001762507-26-000002 · primarydocument.xml · nonDerivative · entry 1 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 672,635 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:42 UTC |
Grund NicholasChief Commercial Officer
|
GrantStock Option (Right to buy) · Derivative | 320,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001661887-26-000001 · primarydocument.xml · derivative · entry 2 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2036-01-30 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:42 UTC |
Grund NicholasChief Commercial Officer
|
GrantCommon Stock | 204,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001661887-26-000001 · primarydocument.xml · nonDerivative · entry 1 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 646,579 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:41 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 320,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001619834-26-000001 · primarydocument.xml · derivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2036-01-30 F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:41 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantCommon Stock | 204,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001619834-26-000001 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,016,090 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2025 and 1,500 shares of the Issuer's common stock purchased on December 31, 2025, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:40 UTC |
Rucci Carolyn M.SVP, Chief Legal Officer
|
GrantStock Option (Right to buy) · Derivative | 270,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0002107264-26-000005 · primarydocument.xml · derivative · entry 2 Rucci Carolyn M. · CIK 0002107264 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,000 Underlying: Common Stock · 270,000 shares Expires 2036-01-30 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:40 UTC |
Rucci Carolyn M.SVP, Chief Legal Officer
|
GrantCommon Stock | 190,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002107264-26-000005 · primarydocument.xml · nonDerivative · entry 1 Rucci Carolyn M. · CIK 0002107264 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 658,150 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:37 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
GrantStock Option (Right to buy) · Derivative | 119,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0002007730-26-000001 · primarydocument.xml · derivative · entry 2 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,000 Underlying: Common Stock · 119,000 shares Expires 2036-01-30 F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:37 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
GrantCommon Stock | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002007730-26-000001 · primarydocument.xml · nonDerivative · entry 1 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,914 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2025 and 1,500 shares of the Issuer's common stock purchased on December 31, 2025, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:36 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
GrantStock Option (Right to buy) · Derivative | 320,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001762507-26-000001 · primarydocument.xml · derivative · entry 2 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2036-01-30 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:36 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
GrantCommon Stock | 204,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001762507-26-000001 · primarydocument.xml · nonDerivative · entry 1 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 707,586 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:35 UTC |
Butler John P.Director · CEO and President
|
GrantStock Option (Right to buy) · Derivative | 1,115,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001591467-26-000001 · primarydocument.xml · derivative · entry 3 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,115,000 Underlying: Common Stock · 1,115,000 shares Expires 2036-01-30 F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:35 UTC |
Butler John P.Director · CEO and President
|
GrantCommon Stock | 743,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001591467-26-000001 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,463,849 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 159,928 shares previously held by John Butler 2019 GRAT, and 1,500 shares of the Issuer's common stock purchased on June 30, 2025 and 1,500 shares of the Issuer's common stock purchased on December 31, 2025, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:01 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
SaleCommon Stock | 41,314 | $3.67 | $151,622.38 |
DisclosureSEC source: 0001562180-25-005201 · primarydocument.xml · nonDerivative · entry 1 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 503,586 F1 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 21, 2024. F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on June 28, 2024. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:15 UTC |
Wolf MylesDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001562180-25-004722 · primarydocument.xml · derivative · entry 2 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2035-06-10 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:15 UTC |
Wolf MylesDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004722 · primarydocument.xml · nonDerivative · entry 1 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,381 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:16 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001562180-25-004723 · primarydocument.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2035-06-10 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:16 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004723 · primarydocument.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,500 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.